image
DEUTSCHLAND BIOTECHNOLOGIE BIONTECH
epa08809507 (FILE) - A view of the signage of German biopharmaceutical company BionTech, which is developing a vaccine against the coronavirus, in Mainz, Germany, 18 March 2020 (reissued 09 November 2020). According to a statement by Mainz-based pharmaceutical company Biontech, its vaccination allegedly offers more than 90 percent protection against the disease Covid-19. EPA/RONALD WITTEK *** Local Caption *** 56039004
Instructions
Licence
Rights Managed
Date de création
20200318
Lieu
MAINZ DEUTSCHLAND
Credit
KEYSTONE
Source
EPA
Byline
RONALD WITTEK
Taille
5263 x 3095 px
Type de fichier
JPEG